NEW YORK, May 22 - Physiome Sciences CEO Jeremy Levin has left the company, which is in the midst of reorganizing itself, GenomeWeb has learned.
Levin left approximately one month ago, according to an insider. His name has been removed from the management portion of the company's web site, though he is still listed as a board member.
Nicholas Hayes, chief operating officer, has assumed the duties of Levin. Hayes joined Physiome in September 2002. Levin had been president and CEO since 1996.
Peter Brooks, vice president of business development and acting vice president for modeling and biological sciences, told GenomeWeb that Physiome will unveil a "new direction" in two weeks.
He would not comment when asked to clarify whether the new direction would entail lay offs. It was also unclear what will happen with the company's R&D collaborations, which include deals with 3rd Millennium and IBM.